Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Michel Bouvier

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Anatomy

Chemicals & Drugs

Physiology

Phenomena

Concepts & Ideas

Genes & Molecular Sequences

Amino Acid Sequence

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
14
Angers, Stéphane
11
Salahpour, Ali
10
Marullo, Stefano
9
Rousseau, Guy
8
Lagacé, Monique
8
Bichet, Daniel
8
Galés, Céline
8
Hebert, Terence
7
Hogue, Mireille
7
Adam, Lynda
6
Breit, Andreas
6
Charest, Pascale
6
Petäjä-Repo, Ulla
6
Terrillon, Sonia
5
Morello, Jean-Pierre

Sign-in to see all Coauthors

Publications

TOP 3
Ramachandran Rithwik; Mihara Koichiro; Mathur Maneesh; Rochdi Moulay Driss; Bouvier Michel; Defea Kathryn; Hollenberg Morley D
Agonist-biased signaling via proteinase activated receptor-2: differential activation of calcium and mitogen-activated protein kinase pathways.
Leduc Martin; Breton Billy; Galés Céline; Le Gouill Christian; Bouvier Michel; Chemtob Sylvain; Heveker Nikolaus
Functional selectivity of natural and synthetic prostaglandin EP4 receptor ligands.
Kobayashi Hiroyuki; Ogawa Koji; Yao Rong; Lichtarge Olivier; Bouvier Michel
Functional rescue of beta-adrenoceptor dimerization and trafficking by pharmacological chaperones.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Michel Bouvier (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Ramachandran Rithwik; Mihara Koichiro; Mathur Maneesh; Rochdi Moulay Driss; Bouvier Michel; Defea Kathryn; Hollenberg Morley D
Agonist-biased signaling via proteinase activated receptor-2: differential activation of calcium and mitogen-activated protein kinase pathways.
Molecular pharmacology 2009;76(4):791-801.
2009: Leduc Martin; Breton Billy; Galés Céline; Le Gouill Christian; Bouvier Michel; Chemtob Sylvain; Heveker Nikolaus
Functional selectivity of natural and synthetic prostaglandin EP4 receptor ligands.
The Journal of pharmacology and experimental therapeutics 2009;331(1):297-307.
2009: Kobayashi Hiroyuki; Ogawa Koji; Yao Rong; Lichtarge Olivier; Bouvier Michel
Functional rescue of beta-adrenoceptor dimerization and trafficking by pharmacological chaperones.
Traffic (Copenhagen, Denmark) 2009;10(8):1019-33.
2008: Pontier Stéphanie M; Percherancier Yann; Galandrin Ségolène; Breit Andreas; Galés Céline; Bouvier Michel
Cholesterol-dependent separation of the beta2-adrenergic receptor from its partners determines signaling efficacy: insight into nanoscale organization of signal transduction.
The Journal of biological chemistry 2008;283(36):24659-72.
2008: Audet Martin; Bouvier Michel
Insights into signaling from the beta2-adrenergic receptor structure.
Nature chemical biology 2008;4(7):397-403.
2008: Galandrin Ségolène; Oligny-Longpré Geneviève; Bonin Hélène; Ogawa Koji; Galés Céline; Bouvier Michel
Conformational rearrangements and signaling cascades involved in ligand-biased mitogen-activated protein kinase signaling through the beta1-adrenergic receptor.
Molecular pharmacology 2008;74(1):162-72.
2008: Audet Nicolas; Galés Céline; Archer-Lahlou Elodie; Vallières Marc; Schiller Peter W; Bouvier Michel; Pineyro Graciela
Bioluminescence resonance energy transfer assays reveal ligand-specific conformational changes within preformed signaling complexes containing delta-opioid receptors and heterotrimeric G proteins.
The Journal of biological chemistry 2008;283(22):15078-88.
2008: Ouedraogo Moussa; Lecat Sandra; Rochdi Moulay Driss; Hachet-Haas Muriel; Matthes Hans; Gicquiaux Hervé; Verrier Sophie; Gaire Mireille; Glasser Nicole; Mély Yves; Takeda Kenneth; Bouvier Michel; Galzi Jean-Luc; Bucher Bernard
Distinct motifs of neuropeptide Y receptors differentially regulate trafficking and desensitization.
Traffic (Copenhagen, Denmark) 2008;9(3):305-24.
2008: Coulon Vincent; Audet Martin; Homburger Vincent; Bockaert Joël; Fagni Laurent; Bouvier Michel; Perroy Julie
Subcellular imaging of dynamic protein interactions by bioluminescence resonance energy transfer.
Biophysical journal 2008;94(3):1001-9.
2007: Galés Céline; Bouvier Michel
[New talk between receptor and trimeric G proteins: "an intertwined body dance"]
Médecine sciences : M/S 2007;23(11):1031-4.
2007: Stefan E; Aquin S; Berger N; Landry C R; Nyfeler B; Bouvier M; Michnick S W
Quantification of dynamic protein complexes using Renilla luciferase fragment complementation applied to protein kinase A activities in vivo.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(43):16916-21.
2007: Héroux Madeleine; Hogue Mireille; Lemieux Sébastien; Bouvier Michel
Functional calcitonin gene-related peptide receptors are formed by the asymmetric assembly of a calcitonin receptor-like receptor homo-oligomer and a monomer of receptor activity-modifying protein-1.
The Journal of biological chemistry 2007;282(43):31610-20.
2007: Hamdan Fadi F; Rochdi Moulay Driss; Breton Billy; Fessart Delphine; Michaud Douce E; Charest Pascale G; Laporte Stéphane A; Bouvier Michel
Unraveling G protein-coupled receptor endocytosis pathways using real-time monitoring of agonist-promoted interaction between beta-arrestins and AP-2.
The Journal of biological chemistry 2007;282(40):29089-100.
2007: Galandrin Ségolène; Oligny-Longpré Geneviève; Bouvier Michel
The evasive nature of drug efficacy: implications for drug discovery.
Trends in pharmacological sciences 2007;28(8):423-30.
2007: Héroux Madeleine; Breton Billy; Hogue Mireille; Bouvier Michel
Assembly and signaling of CRLR and RAMP1 complexes assessed by BRET.
Biochemistry 2007;46(23):7022-33.
2007: Fessart Delphine; Simaan May; Zimmerman Brandon; Comeau Jonathan; Hamdan Fadi F; Wiseman Paul W; Bouvier Michel; Laporte Stéphane A
Src-dependent phosphorylation of beta2-adaptin dissociates the beta-arrestin-AP-2 complex.
Journal of cell science 2007;120(Pt 10):1723-32.
2007: Bouvier Michel
When an inhibitor promotes activity.
Chemistry & biology 2007;14(3):241-2.
2007: Boeglin Damien; Hamdan Fadi F; Melendez Rosa E; Cluzeau Jérôme; Laperriere Andre; Héroux Madeleine; Bouvier Michel; Lubell William D
Calcitonin gene-related peptide analogues with aza and indolizidinone amino acid residues reveal conformational requirements for antagonist activity at the human calcitonin gene-related peptide 1 receptor.
Journal of medicinal chemistry 2007;50(6):1401-8.
2007: Charest Pascale G; Oligny-Longpré Geneviève; Bonin Hélène; Azzi Mounia; Bouvier Michel
The V2 vasopressin receptor stimulates ERK1/2 activity independently of heterotrimeric G protein signalling.
Cellular signalling 2007;19(1):32-41.
2006: Galandrin Ségolène; Bouvier Michel
Distinct signaling profiles of beta1 and beta2 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy.
Molecular pharmacology 2006;70(5):1575-84.
2006: Galés Céline; Van Durm Joost J J; Schaak Stéphane; Pontier Stéphanie; Percherancier Yann; Audet Martin; Paris Hervé; Bouvier Michel
Probing the activation-promoted structural rearrangements in preassembled receptor-G protein complexes.
Nature structural & molecular biology 2006;13(9):778-86.
2006: Breit Andreas; Gagnidze Khatuna; Devi Lakshmi A; Lagacé Monique; Bouvier Michel
Simultaneous activation of the delta opioid receptor (deltaOR)/sensory neuron-specific receptor-4 (SNSR-4) hetero-oligomer by the mixed bivalent agonist bovine adrenal medulla peptide 22 activates SNSR-4 but inhibits deltaOR signaling.
Molecular pharmacology 2006;70(2):686-96.
2006: Rebois R Victor; Robitaille Mélanie; Galés Céline; Dupré Denis J; Baragli Alessandra; Trieu Phan; Ethier Nathalie; Bouvier Michel; Hébert Terence E
Heterotrimeric G proteins form stable complexes with adenylyl cyclase and Kir3.1 channels in living cells.
Journal of cell science 2006;119(Pt 13):2807-18.
2006: Pontier Stéphanie M; Lahaie Nicolas; Ginham Rachel; St-Gelais Fannie; Bonin Hélène; Bell David J; Flynn Helen; Trudeau Louis-Eric; McIlhinney Jeffrey; White Julia H; Bouvier Michel
Coordinated action of NSF and PKC regulates GABAB receptor signaling efficacy.
The EMBO journal 2006;25(12):2698-709.
2006: Petäjä-Repo Ulla E; Hogue Mireille; Leskelä Tarja T; Markkanen Piia M H; Tuusa Jussi T; Bouvier Michel
Distinct subcellular localization for constitutive and agonist-modulated palmitoylation of the human delta opioid receptor.
The Journal of biological chemistry 2006;281(23):15780-9.
2006: Hamdan Fadi F; Percherancier Yann; Breton Billy; Bouvier Michel
Monitoring protein-protein interactions in living cells by bioluminescence resonance energy transfer (BRET).
Current protocols in neuroscience / editorial board, Jacqueline N. Crawley ... [et al.] 2006;Chapter 5():Unit 5.23.
2006: Barbas Demian; Zappulla Jacques P; Angers Stéphane; Bouvier Michel; Mohamed Habib A; Byrne John H; Castellucci Vincent F; DesGroseillers Luc
An aplysia dopamine1-like receptor: molecular and functional characterization.
Journal of neurochemistry 2006;96(2):414-27.
2006: Bernier Virginie; Morello Jean-Pierre; Zarruk Alexandro; Debrand Nicolas; Salahpour Ali; Lonergan Michèle; Arthus Marie-Françoise; Laperrière André; Brouard Rémi; Bouvier Michel; Bichet Daniel G
Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus.
Journal of the American Society of Nephrology : JASN 2006;17(1):232-43.
2005: Storez Hélène; Scott Mark G H; Issafras Hassan; Burtey Anne; Benmerah Alexandre; Muntaner Olivier; Piolot Tristan; Tramier Marc; Coppey-Moisan Maité; Bouvier Michel; Labbé-Jullié Catherine; Marullo Stefano
Homo- and hetero-oligomerization of beta-arrestins in living cells.
The Journal of biological chemistry 2005;280(48):40210-5.
2005: Hamdan Fadi F; Audet Martin; Garneau Philippe; Pelletier Jerry; Bouvier Michel
High-throughput screening of G protein-coupled receptor antagonists using a bioluminescence resonance energy transfer 1-based beta-arrestin2 recruitment assay.
Journal of biomolecular screening : the official journal of the Society for Biomolecular Screening 2005;10(5):463-75.
2005: Zhu Wei-Zhong; Chakir Khalid; Zhang Shengjun; Yang Dongmei; Lavoie Catherine; Bouvier Michel; Hébert Terence E; Lakatta Edward G; Cheng Heping; Xiao Rui-Ping
Heterodimerization of beta1- and beta2-adrenergic receptor subtypes optimizes beta-adrenergic modulation of cardiac contractility.
Circulation research 2005;97(3):244-51.
2005: Villemure Josée-France; Adam Lynda; Bevan Nicola J; Gearing Katy; Chénier Sébastien; Bouvier Michel
Subcellular distribution of GABA(B) receptor homo- and hetero-dimers.
The Biochemical journal 2005;388(Pt 1):47-55.
2005: Charest Pascale G; Terrillon Sonia; Bouvier Michel
Monitoring agonist-promoted conformational changes of beta-arrestin in living cells by intramolecular BRET.
EMBO reports 2005;6(4):334-40.
2005: Galés Céline; Rebois R Victor; Hogue Mireille; Trieu Phan; Breit Andreas; Hébert Terence E; Bouvier Michel
Real-time monitoring of receptor and G-protein interactions in living cells.
Nature methods 2005;2(3):177-84.
2005: Percherancier Yann; Berchiche Yamina A; Slight Isabelle; Volkmer-Engert Rudolf; Tamamura Hirokazu; Fujii Nobutaka; Bouvier Michel; Heveker Nikolaus
Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo- and heterodimers.
The Journal of biological chemistry 2005;280(11):9895-903.
2005: Piñeyro Graciela; Azzi Mounia; deLéan André; Schiller Peter W; Bouvier Michel
Reciprocal regulation of agonist and inverse agonist signaling efficacy upon short-term treatment of the human delta-opioid receptor with an inverse agonist.
Molecular pharmacology 2005;67(1):336-48.
2004: Perroy Julie; Pontier Stephanie; Charest Pascale G; Aubry Muriel; Bouvier Michel
Real-time monitoring of ubiquitination in living cells by BRET.
Nature methods 2004;1(3):203-8.
2004: Granier Sébastien; Terrillon Sonia; Pascal Robert; Déméné Hélène; Bouvier Michel; Guillon Gilles; Mendre Christiane
A cyclic peptide mimicking the third intracellular loop of the V2 vasopressin receptor inhibits signaling through its interaction with receptor dimer and G protein.
The Journal of biological chemistry 2004;279(49):50904-14.
2004: Terrillon Sonia; Bouvier Michel
Receptor activity-independent recruitment of betaarrestin2 reveals specific signalling modes.
The EMBO journal 2004;23(20):3950-61.
2004: Bernier Virginie; Bichet Daniel G; Bouvier Michel
Pharmacological chaperone action on G-protein-coupled receptors.
Current opinion in pharmacology 2004;4(5):528-33.
2004: Qanbar Riad; Bouvier Michel
Determination of protein-bound palmitate turnover rates using a three-compartment model that formally incorporates [3H]palmitate recycling.
Biochemistry 2004;43(38):12275-88.
2004: Registre Marilyn; Goetz Jacky G; St Pierre Pascal; Pang Hao; Lagacé Monique; Bouvier Michel; Le Phuong U; Nabi Ivan R
The gene product of the gp78/AMFR ubiquitin E3 ligase cDNA is selectively recognized by the 3F3A antibody within a subdomain of the endoplasmic reticulum.
Biochemical and biophysical research communications 2004;320(4):1316-22.
2004: Bernier Virginie; Lagacé Monique; Lonergan Michèle; Arthus Marie-Françoise; Bichet Daniel G; Bouvier Michel
Functional rescue of the constitutively internalized V2 vasopressin receptor mutant R137H by the pharmacological chaperone action of SR49059.
Molecular endocrinology (Baltimore, Md.) 2004;18(8):2074-84.
2004: Salahpour Ali; Angers Stéphane; Mercier Jean-François; Lagacé Monique; Marullo Stefano; Bouvier Michel
Homodimerization of the beta2-adrenergic receptor as a prerequisite for cell surface targeting.
The Journal of biological chemistry 2004;279(32):33390-7.
2004: Bernier Virginie; Lagacé Monique; Bichet Daniel G; Bouvier Michel
Pharmacological chaperones: potential treatment for conformational diseases.
Trends in endocrinology and metabolism: TEM 2004;15(5):222-8.
2004: Breit Andreas; Lagacé Monique; Bouvier Michel
Hetero-oligomerization between beta2- and beta3-adrenergic receptors generates a beta-adrenergic signaling unit with distinct functional properties.
The Journal of biological chemistry 2004;279(27):28756-65.
2004: Terrillon Sonia; Barberis Claude; Bouvier Michel
Heterodimerization of V1a and V2 vasopressin receptors determines the interaction with beta-arrestin and their trafficking patterns.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(6):1548-53.
2004: Terrillon Sonia; Bouvier Michel
Roles of G-protein-coupled receptor dimerization.
EMBO reports 2004;5(1):30-4.
2003: Charest Pascale G; Bouvier Michel
Palmitoylation of the V2 vasopressin receptor carboxyl tail enhances beta-arrestin recruitment leading to efficient receptor endocytosis and ERK1/2 activation.
The Journal of biological chemistry 2003;278(42):41541-51.
2003: Azzi Mounia; Charest Pascale G; Angers Stéphane; Rousseau Guy; Kohout Trudy; Bouvier Michel; Piñeyro Graciela
Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(20):11406-11.
2003: Perroy Julie; Adam Lynda; Qanbar Riad; Chénier Sébastien; Bouvier Michel
Phosphorylation-independent desensitization of GABA(B) receptor by GRK4.
The EMBO journal 2003;22(15):3816-24.
2003: Germain-Desprez Delphine; Bazinet Martine; Bouvier Michel; Aubry Muriel
Oligomerization of transcriptional intermediary factor 1 regulators and interaction with ZNF74 nuclear matrix protein revealed by bioluminescence resonance energy transfer in living cells.
The Journal of biological chemistry 2003;278(25):22367-73.
2003: Terrillon Sonia; Durroux Thierry; Mouillac Bernard; Breit Andreas; Ayoub Mohammed A; Taulan Magali; Jockers Ralf; Barberis Claude; Bouvier Michel
Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis.
Molecular endocrinology (Baltimore, Md.) 2003;17(4):677-91.
2003: Salahpour Ali; Bonin Hélène; Bhalla Suparna; Petäjä-Repo Ulla; Bouvier Michel
Biochemical characterization of beta2-adrenergic receptor dimers and oligomers.
Biological chemistry 2003;384(1):117-23.
2003: Qanbar Riad; Bouvier Michel
Role of palmitoylation/depalmitoylation reactions in G-protein-coupled receptor function.
Pharmacology & therapeutics 2003;97(1):1-33.
2002: Lavine Natalie; Ethier Nathalie; Oak James N; Pei Lin; Liu Fang; Trieu Phan; Rebois R Victor; Bouvier Michel; Hebert Terence E; Van Tol Hubert H M
G protein-coupled receptors form stable complexes with inwardly rectifying potassium channels and adenylyl cyclase.
The Journal of biological chemistry 2002;277(48):46010-9.
2002: Mercier Jean-François; Salahpour Ali; Angers Stéphane; Breit Andreas; Bouvier Michel
Quantitative assessment of beta 1- and beta 2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer.
The Journal of biological chemistry 2002;277(47):44925-31.
2002: Lavoie Catherine; Mercier Jean-Francois; Salahpour Ali; Umapathy Dhiviya; Breit Andreas; Villeneuve Louis-Robert; Zhu Wei-Zhong; Xiao Rui-Ping; Lakatta Edward G; Bouvier Michel; Hébert Terence E
Beta 1/beta 2-adrenergic receptor heterodimerization regulates beta 2-adrenergic receptor internalization and ERK signaling efficacy.
The Journal of biological chemistry 2002;277(38):35402-10.
2002: Issafras Hassan; Angers Stéphane; Bulenger Sébastien; Blanpain Cédric; Parmentier Marc; Labbé-Jullié Catherine; Bouvier Michel; Marullo Stefano
Constitutive agonist-independent CCR5 oligomerization and antibody-mediated clustering occurring at physiological levels of receptors.
The Journal of biological chemistry 2002;277(38):34666-73.
2002: Ayoub Mohammed A; Couturier Cyril; Lucas-Meunier Estelle; Angers Stephane; Fossier Philippe; Bouvier Michel; Jockers Ralf
Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer.
The Journal of biological chemistry 2002;277(24):21522-8.
2002: Petäjä-Repo Ulla E; Hogue Mireille; Bhalla Suparna; Laperrière André; Morello Jean-Pierre; Bouvier Michel
Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturation.
The EMBO journal 2002;21(7):1628-37.
2002: Bertrand Lucie; Parent Stéphane; Caron Mireille; Legault Mireille; Joly Erik; Angers Stéphane; Bouvier Michel; Brown Mike; Houle Benoit; Ménard Luc
The BRET2/arrestin assay in stable recombinant cells: a platform to screen for compounds that interact with G protein-coupled receptors (GPCRS).
Journal of receptor and signal transduction research 2002;22(1-4):533-41.
2002: Barbas Demian; Zappulla Jacques P; Angers Stéphane; Bouvier Michel; Castellucci Vincent F; DesGroseillers Luc
Functional characterization of a novel serotonin receptor (5-HTap2) expressed in the CNS of Aplysia californica.
Journal of neurochemistry 2002;80(2):335-45.
2002: Angers Stephane; Salahpour Ali; Bouvier Michel
Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function.
Annual review of pharmacology and toxicology 2002;42():409-35.
2001: Azzi M; Piñeyro G; Pontier S; Parent S; Ansanay H; Bouvier M
Allosteric effects of G protein overexpression on the binding of beta-adrenergic ligands with distinct inverse efficacies.
Molecular pharmacology 2001;60(5):999-1007.
2001: Hilairet S; Bélanger C; Bertrand J; Laperrière A; Foord S M; Bouvier M
Agonist-promoted internalization of a ternary complex between calcitonin receptor-like receptor, receptor activity-modifying protein 1 (RAMP1), and beta-arrestin.
The Journal of biological chemistry 2001;276(45):42182-90.
2001: Piñeyro G; Azzi M; De Léan A; Schiller P; Bouvier M
Short-term inverse-agonist treatment induces reciprocal changes in delta-opioid agonist and inverse-agonist binding capacity.
Molecular pharmacology 2001;60(4):816-27.
2001: Hilairet S; Foord S M; Marshall F H; Bouvier M
Protein-protein interaction and not glycosylation determines the binding selectivity of heterodimers between the calcitonin receptor-like receptor and the receptor activity-modifying proteins.
The Journal of biological chemistry 2001;276(31):29575-81.
2001: Rousseau G; Haddad P S; Gallo-Payet N; Bouvier M
Ca(2+)-dependent sensitization of adenylyl cyclase activity.
European journal of pharmacology 2001;422(1-3):53-60.
2001: Bélanger C; Ansanay H; Qanbar R; Bouvier M
Primary sequence requirements for S-acylation of beta(2)-adrenergic receptor peptides.
FEBS letters 2001;499(1-2):59-64.
2001: Morello J P; Salahpour A; Petäjä-Repo U E; Laperrière A; Lonergan M; Arthus M F; Nabi I R; Bichet D G; Bouvier M
Association of calnexin with wild type and mutant AVPR2 that causes nephrogenic diabetes insipidus.
Biochemistry 2001;40(23):6766-75.
2001: Angers S; Salahpour A; Bouvier M
Biochemical and biophysical demonstration of GPCR oligomerization in mammalian cells.
Life sciences 2001;68(19-20):2243-50.
2001: Bouvier M
Oligomerization of G-protein-coupled transmitter receptors.
Nature reviews. Neuroscience 2001;2(4):274-86.
2001: Laurent C E; Cardinal R; Rousseau G; Vermeulen M; Bouchard C; Wilkinson M; Armour J A; Bouvier M
Functional desensitization to isoproterenol without reducing cAMP production in canine failing cardiocytes.
American journal of physiology. Regulatory, integrative and comparative physiology 2001;280(2):R355-64.
2001: Petaja-Repo U E; Hogue M; Laperriere A; Bhalla S; Walker P; Bouvier M
Newly synthesized human delta opioid receptors retained in the endoplasmic reticulum are retrotranslocated to the cytosol, deglycosylated, ubiquitinated, and degraded by the proteasome.
The Journal of biological chemistry 2001;276(6):4416-23.
2001: Moffett S; Rousseau G; Lagacé M; Bouvier M
The palmitoylation state of the beta(2)-adrenergic receptor regulates the synergistic action of cyclic AMP-dependent protein kinase and beta-adrenergic receptor kinase involved in its phosphorylation and desensitization.
Journal of neurochemistry 2001;76(1):269-79.
2000: Morello J P; Petäjä-Repo U E; Bichet D G; Bouvier M
Pharmacological chaperones: a new twist on receptor folding.
Trends in pharmacological sciences 2000;21(12):466-9.
2000: Salahpour A; Angers S; Bouvier M
Functional significance of oligomerization of G-protein-coupled receptors.
Trends in endocrinology and metabolism: TEM 2000;11(5):163-8.
2000: Petaja-Repo U E; Hogue M; Laperriere A; Walker P; Bouvier M
Export from the endoplasmic reticulum represents the limiting step in the maturation and cell surface expression of the human delta opioid receptor.
The Journal of biological chemistry 2000;275(18):13727-36.
2000: Morello J P; Salahpour A; Laperrière A; Bernier V; Arthus M F; Lonergan M; Petäjä-Repo U; Angers S; Morin D; Bichet D G; Bouvier M
Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants.
The Journal of clinical investigation 2000;105(7):887-95.
2000: Angers S; Salahpour A; Joly E; Hilairet S; Chelsky D; Dennis M; Bouvier M
Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET).
Proceedings of the National Academy of Sciences of the United States of America 2000;97(7):3684-9.
1999: Loisel T P; Ansanay H; Adam L; Marullo S; Seifert R; Lagacé M; Bouvier M
Activation of the beta(2)-adrenergic receptor-Galpha(s) complex leads to rapid depalmitoylation and inhibition of repalmitoylation of both the receptor and Galpha(s).
The Journal of biological chemistry 1999;274(43):31014-9.
1999: Jockers R; Angers S; Da Silva A; Benaroch P; Strosberg A D; Bouvier M; Marullo S
Beta(2)-adrenergic receptor down-regulation. Evidence for a pathway that does not require endocytosis.
The Journal of biological chemistry 1999;274(41):28900-8.
1999: Adam L; Bouvier M; Jones T L
Nitric oxide modulates beta(2)-adrenergic receptor palmitoylation and signaling.
The Journal of biological chemistry 1999;274(37):26337-43.
1999: Marquis M; Fenrick R; Pedro L; Bouvier M; De Léan A
Comparative binding study of rat natriuretic peptide receptor-A.
Molecular and cellular biochemistry 1999;194(1-2):23-30.
1998: Hebert T E; Loisel T P; Adam L; Ethier N; Onge S S; Bouvier M
Functional rescue of a constitutively desensitized beta2AR through receptor dimerization.
The Biochemical journal 1998;330 ( Pt 1)():287-93.
1998: Bouvier M; Rousseau G
Subtype-specific regulation of the beta-adrenergic receptors.
Advances in pharmacology (San Diego, Calif.) 1998;42():433-8.
1997: Loisel T P; Ansanay H; St-Onge S; Gay B; Boulanger P; Strosberg A D; Marullo S; Bouvier M
Recovery of homogeneous and functional beta 2-adrenergic receptors from extracellular baculovirus particles.
Nature biotechnology 1997;15(12):1300-4.
1997: Lacroix A; Tremblay J; Rousseau G; Bouvier M; Hamet P
Propranolol therapy for ectopic beta-adrenergic receptors in adrenal Cushing's syndrome.
The New England journal of medicine 1997;337(20):1429-34.
1997: Murphy R J; Gardiner P F; Rousseau G; Bouvier M; Béliveau L
Chronic beta-blockade increases skeletal muscle beta-adrenergic-receptor density and enhances contractile force.
Journal of applied physiology (Bethesda, Md. : 1985) 1997;83(2):459-65.
1997: Rousseau G; Guilbault N; Da Silva A; Mouillac B; Chidiac P; Bouvier M
Influence of receptor density on the patterns of beta2-adrenocepter desensitization.
European journal of pharmacology 1997;326(1):75-84.
1996: Loisel T P; Adam L; Hebert T E; Bouvier M
Agonist stimulation increases the turnover rate of beta 2AR-bound palmitate and promotes receptor depalmitoylation.
Biochemistry 1996;35(49):15923-32.
1996: Chidiac P; Nouet S; Bouvier M
Agonist-induced modulation of inverse agonist efficacy at the beta 2-adrenergic receptor.
Molecular pharmacology 1996;50(3):662-9.
1996: Moffett S; Adam L; Bonin H; Loisel T P; Bouvier M; Mouillac B
Palmitoylated cysteine 341 modulates phosphorylation of the beta2-adrenergic receptor by the cAMP-dependent protein kinase.
The Journal of biological chemistry 1996;271(35):21490-7.
1996: Hebert T E; Moffett S; Morello J P; Loisel T P; Bichet D G; Barret C; Bouvier M
A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation.
The Journal of biological chemistry 1996;271(27):16384-92.
1996: Rousseau G; Nantel F; Bouvier M
Distinct receptor domains determine subtype-specific coupling and desensitization phenotypes for human beta1- and beta2-adrenergic receptors.
Molecular pharmacology 1996;49(4):752-60.
1995: Valiquette M; Parent S; Loisel T P; Bouvier M
Mutation of tyrosine-141 inhibits insulin-promoted tyrosine phosphorylation and increased responsiveness of the human beta 2-adrenergic receptor.
The EMBO journal 1995;14(22):5542-9.
1995: Bouvier M; Loisel T P; Hebert T
Dynamic regulation of G-protein coupled receptor palmitoylation: potential role in receptor function.
Biochemical Society transactions 1995;23(3):577-81.
1995: Nantel F; Bouvier M; Strosberg A D; Marullo S
Functional effects of long-term activation on human beta 2- and beta 3-adrenoceptor signalling.
British journal of pharmacology 1995;114(5):1045-51.
1995: Marullo S; Nantel F; Strosberg A D; Bouvier M
Variability in the regulation of beta-adrenoceptor subtypes.
Biochemical Society transactions 1995;23(1):126-9.
1995: Bouvier M; Moffett S; Loisel T P; Mouillac B; Hebert T; Chidiac P
Palmitoylation of G-protein-coupled receptors: a dynamic modification with functional consequences.
Biochemical Society transactions 1995;23(1):116-20.
1995: Bouvier M; Chidiac P; Hebert T E; Loisel T P; Moffett S; Mouillac B
Dynamic palmitoylation of G-protein-coupled receptors in eukaryotic cells.
Methods in enzymology 1995;250():300-14.
1994: St-Onge S; Chidiac P; Brakier-Gingras L; Bouvier M
Beta-adrenergic receptor desensitization in the early stage of hereditary cardiomyopathy in hamsters.
Canadian journal of physiology and pharmacology 1994;72(8):875-83.
1994: Nantel F; Marullo S; Krief S; Strosberg A D; Bouvier M
Cell-specific down-regulation of the beta 3-adrenergic receptor.
The Journal of biological chemistry 1994;269(18):13148-55.
1994: Chidiac P; Hebert T E; Valiquette M; Dennis M; Bouvier M
Inverse agonist activity of beta-adrenergic antagonists.
Molecular pharmacology 1994;45(3):490-9.
1993: Suzuki T; Nantel F; Bonin H; Valiquette M; Bouvier M
Cellular characterization of the pharmacological selectivity and tachyphylactic properties of denopamine for the human beta adrenergic receptors.
The Journal of pharmacology and experimental therapeutics 1993;267(2):785-90.
1993: Valiquette M; Bonin H; Bouvier M
Mutation of tyrosine-350 impairs the coupling of the beta 2-adrenergic receptor to the stimulatory guanine nucleotide binding protein without interfering with receptor down-regulation.
Biochemistry 1993;32(19):4979-85.
1993: Nantel F; Bonin H; Emorine L J; Zilberfarb V; Strosberg A D; Bouvier M; Marullo S
The human beta 3-adrenergic receptor is resistant to short term agonist-promoted desensitization.
Molecular pharmacology 1993;43(4):548-55.
1993: Moffett S; Mouillac B; Bonin H; Bouvier M
Altered phosphorylation and desensitization patterns of a human beta 2-adrenergic receptor lacking the palmitoylated Cys341.
The EMBO journal 1993;12(1):349-56.
1992: Mouillac B; Caron M; Bonin H; Dennis M; Bouvier M
Agonist-modulated palmitoylation of beta 2-adrenergic receptor in Sf9 cells.
The Journal of biological chemistry 1992;267(30):21733-7.
1992: Suzuki T; Nguyen C T; Nantel F; Bonin H; Valiquette M; Frielle T; Bouvier M
Distinct regulation of beta 1- and beta 2-adrenergic receptors in Chinese hamster fibroblasts.
Molecular pharmacology 1992;41(3):542-8.
1991: Bouvier M; Guilbault N; Bonin H
Phorbol-ester-induced phosphorylation of the beta 2-adrenergic receptor decreases its coupling to Gs.
FEBS letters 1991;279(2):243-8.
1990: Valiquette M; Bonin H; Hnatowich M; Caron M G; Lefkowitz R J; Bouvier M
Involvement of tyrosine residues located in the carboxyl tail of the human beta 2-adrenergic receptor in agonist-induced down-regulation of the receptor.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(13):5089-93.
1989: de Champlain J; Eid H; Drolet G; Bouvier M; Foucart S
Peripheral neurogenic mechanisms in deoxycorticosterone acetate--salt hypertension in the rat.
Canadian journal of physiology and pharmacology 1989;67(9):1140-5.
1989: Drolet G; Bouvier M; de Champlain J
Enhanced sympathoadrenal reactivity to haemorrhagic stress in DOCA-salt hypertensive rats.
Journal of hypertension 1989;7(3):237-42.
1987: de Champlain J; Bouvier M; Drolet G
Abnormal regulation of the sympathoadrenal system in deoxycorticosterone acetate-salt hypertensive rats.
Canadian journal of physiology and pharmacology 1987;65(8):1605-14.
1985: de Champlain J; Bouvier M; Gravel N; Cléroux J; Drolet G; Foucart S; Eid H
[Role of the sympathetic nervous system in arterial hypertension]
L'unión médicale du Canada 1985;114(12):977-81, 986.

Sign-in to see more